{
    "code": "51060836",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51060836",
    "time": "2021-12-03 03:35:03",
    "許可證字號": "衛部藥製字第060836號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/03\/08",
    "發證\/登錄日期": "110\/03\/08",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY05106083606",
    "中文品名": "克壓脂膜衣錠5毫克\/20毫克",
    "英文品名": "Dualpress F.C. Tablets 5mg\/20mg",
    "適應症": "因有高血壓和血脂異常這兩種可矯正的危險因子併存，而使心血管危險增加的病人；或因有心絞痛為表現之冠心病（CHD）併有可矯正的血脂異常危險因子，而使心血管危險增加的病人。降低冠心病高危險群的心血管事件發生率對於臨床上沒有冠心病的高血壓病人，但是至少有三個其他冠心病危險因子，包括第二型糖尿病、年紀大於等於55歲、微白蛋白尿或蛋白尿、吸煙、或第一等親在55歲（男性）或60歲（女性）前曾經發生冠心病事件，適用於：降低心肌梗塞的風險、降低中風的風險、降低血管再造術與心絞痛的風險。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠ALU-ALU鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "監視期滿學名藥",
    "監視期限": "",
    "主成分略述": "ATORVASTATIN CALCIUM TRIHYDRATE, AMLODIPINE BESYLATE",
    "限制項目": "01國　產 24監視期滿學名藥 62完成溶離率試驗",
    "申請商名稱": "6141010064  生達化學製藥股份有限公司二廠",
    "申請商地址": "台南市新營區開元路154號",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2406003150",
            "成分名稱": "ATORVASTATIN CALCIUM TRIHYDRATE",
            "含量描述": "(equivalent to Atorvastatin.....20mg)",
            "含量": "21.7000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2412402210",
            "成分名稱": "AMLODIPINE BESYLATE",
            "含量描述": "(equivalent to Amlodipine.....5mg)",
            "含量": "6.9400000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Dualpress F.C. Tablets 5mg and 20mg藥品外觀-110-03-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51060836&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Dualpress F.C. Tablets 5mg and 20mg-仿單-2-110-03-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51060836&Seq=001&Type=9"
        },
        {
            "title": "Dualpress F.C. Tablets 5mg and 20mg-PTP-110-03-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51060836&Seq=003&Type=8"
        },
        {
            "title": "Dualpress F.C. Tablets 5mg and 20mg-1000錠LB-110-03-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51060836&Seq=002&Type=8"
        },
        {
            "title": "Dualpress F.C. Tablets 5mg and 20mg-30錠BX-110-03-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51060836&Seq=001&Type=8"
        }
    ]
}